Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07306767
Eligibility Criteria:
Inclusion Criteria:
* Male participants aged 50 years or older.
* Lower urinary tract symptoms secondary to benign prostatic hyperplasia.
* Moderate to severe symptoms with International Prostate Symptom Score 15 to 35.
* Prostate volume 30 to 100 millilitres.
* Maximum urinary flow rate less than 15 millilitres per second.
* No hydronephrosis due to bladder outlet obstruction.
* Normal prostate-specific antigen or normal free-to-total prostate-specific antigen ratio.
Exclusion Criteria:
* History of prostate, bladder, or lower urinary tract surgery.
* Neurological disease affecting lower urinary tract function.
* Active urinary tract infection and/or symptomatic urinary tract stones.
* Post-void residual urine volume greater than 200 millilitres.
* Urethral stricture.
* Prostate cancer or bladder cancer.
Sex:
MALE
Minimum Age:
50 Years
Study:
NCT07306767
Study Brief:
Protocol Section:
NCT07306767